Highnoon Laboratories Announces New Board of Directors

Lahore: Highnoon Laboratories Limited has successfully conducted its Extraordinary General Meeting on September 02, 2024, where a new slate of directors was elected for a three-year term commencing on September 03, 2024.

According to information available from the Pakistan Stock Exchange (PSX), the election results introduced a mix of independent and other directors to steer the company through its next phase of strategic operations. The newly elected board members include Ms. Tehmina Saeed Chaudhury, serving as a female director, and Mr. Ramesh Alexander Iddamalgoda Efapata and Mr. Tariq Wajid, both appointed as independent directors.

Other directors appointed include Mr. Tausif Ahmad Khan, Dr. Adeel Abbas Haideri, Mr. Tauqir Ahmed Khan, and Mr. Taufiq Ahmed Khan, each bringing a diverse range of expertise and experience to the board. The selection of directors aims to enhance governance and oversight, aligning with the company’s commitment to maintaining robust leadership and strategic guidance.

The shareholder’s meeting underscored the company’s focus on diversity and strong governance structures to navigate the evolving pharmaceutical industry landscape. These appointments are pivotal as Highnoon Laboratories continues to innovate and expand its market presence.

The post Highnoon Laboratories Announces New Board of Directors appeared first on .